<Record>
<Term>Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Antineoplastic Vaccine</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Vaccine/Antineoplastic Vaccine/Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine</BroaderTerm>
<BroaderTerm>Antineoplastic Vaccine</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Vaccine</BroaderTerm>
<Synonym>Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine</Synonym>
<Description>A cell-based vaccine composed of autologous tumor cells fused with Epstein-Barr virus-transformed B-lymphoblastoid cells. Upon administration, this vaccine may stimulate a cytotoxic T cell response against tumor cells, resulting in tumor cell lysis. (NCI05)</Description>
<Source>NCI Thesaurus</Source>
</Record>
